Galena Biopharma, Inc.
(NASDAQ : GALE)

( )
GALE PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Loading GALE News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
1.30%83.341.8%$745.39m
BIIBBiogen Inc.
1.17%241.711.0%$581.03m
CELGCelgene Corporation
-0.30%98.511.2%$467.26m
AMGNAmgen Inc.
1.37%152.151.0%$450.08m
REGNRegeneron Pharmaceuticals, Inc.
0.39%349.233.1%$325.50m
ALXNAlexion Pharmaceuticals, Inc.
2.27%116.762.5%$311.51m
ILMNIllumina, Inc.
1.97%140.294.9%$169.60m
TSROTESARO, Inc.
8.59%84.0515.8%$143.75m
VRTXVertex Pharmaceuticals Incorporated
1.20%86.022.6%$133.88m
MDVNMedivation, Inc.
-1.07%60.302.8%$132.96m
BMRNBioMarin Pharmaceutical Inc.
-0.73%77.804.0%$128.97m
AAgilent Technologies, Inc.
1.35%44.351.0%$104.36m
SRPTSarepta Therapeutics, Inc.
2.20%19.0749.4%$104.18m
EXASExact Sciences Corporation
8.50%12.2521.4%$102.22m
ACADACADIA Pharmaceuticals Inc.
0.25%32.4619.6%$95.68m

Company Profile

Galena Biopharma, Inc. engages as a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major unmet medical needs. It focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral (fentanyl) sublingual tablets and Zuplenz (ondansetron) oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA.